XML 68 R50.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaborative Agreements (Details) - Collaborative Arrangement, Product [Member]
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 28, 2016
Aug. 07, 2015
USD ($)
product
Nov. 14, 2014
Apr. 30, 2015
USD ($)
Sep. 30, 2013
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Upfront payment received         $ 10,000        
INO-3112 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Revenue recognized   $ 15,000              
License To Research Collaboration Products [Member] | Nonsoftware License Arrangement [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue, additions   12,500              
INO 5150 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Revenue recognized         5,000        
INO 1800 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Revenue recognized         3,400        
Option Right [Member] | Nonsoftware License Arrangement [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue, additions         1,500        
Joint Steering Committee Obligation [Member] | Nonsoftware License Arrangement [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue, additions         155        
MedImmune [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Upfront payment received   27,500              
Anticipated development and regulatory event based payment receivable milestones   $ 700,000              
Number of additional products to be developed | product   2              
Revenue under collaborative research and development arrangements           $ 581 $ 15,100 $ 1,300 $ 15,100
Deferred revenue           13,600   13,600  
Accounts receivable           1,000   1,000  
Hoffman-La Roche [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Upfront payment received         10,000        
Anticipated development and regulatory event based payment receivable milestones         $ 3,000        
Revenue under collaborative research and development arrangements                 3,000
Deferred revenue           226   226  
Accounts receivable           4,800   4,800  
Previously deferred revenue recognized           1,700 1,300 4,700 9,900
Hoffman-La Roche [Member] | INO 5150 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Days subsequent to termination notice effective     90 days            
Hoffman-La Roche [Member] | INO 1800 [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Days subsequent to termination notice effective 90 days                
Defense Advanced Research Projects Agency (DARPA) [Member]                  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]                  
Deferred revenue           1,300   1,300  
Accounts receivable           11,000   11,000  
Term       2 years          
Base award       $ 19,600          
Option award       24,600          
Second option award       $ 11,100          
Previously deferred revenue recognized           $ 9,400 $ 7,300 $ 17,600 $ 7,300